-+ 0.00%
-+ 0.00%
-+ 0.00%

DYNE THERAPEUTICS, INC - REQUESTS PRIORITY REVIEW FOR BLA TO SHORTEN FDA REVIEW TO 6 MONTHS

Reuters·05/26/2026 11:30:00

Please log in to view news